Author

Adam Burgener

Karolinska InstitutetORCID 0000-0002-2303-5738Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1

Frequent Co-Authors

Florian HladikiD· 3 shared Alana LamontiD· 2 shared Alicia R. BerardiD· 2 shared Damilola C. LaworeiD· 2 shared Douglas K. BrubakeriD· 2 shared Elizabeth IrunguiD· 2 shared Elly Katabira· 2 shared Fernanda L. Calienes· 2 shared

Activity by Year

2015-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Florian HladikORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Systems BiologyFrontiers in MicrobiologyPeer-reviewedSep 16, 2025

Computational Microbiome Pharmacology Analysis Elucidates the Anti-Cancer Potential of Vaginal Microbes and Metabolites

Damilola C. Lawore, Smrutiti Jena, Alicia R. Berard…·Douglas K. Brubaker

The paper develops a systems biology framework called the Pharmacobiome to analyze the anti-cancer potential of vaginal microbes and metabolites by comparing their effects on host gene expression to known drugs.

3 citations

humanmetagenomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintAug 28, 2025

Identifying a Vaginal Microbiome-Derived Selective Antibiotic Metabolite via Microbiome Pharmacology Analysis

Smrutiti Jena, Damilola C. Lawore, Javier Muñoz Briones…·Douglas K. Brubaker

This study identifies a vaginal microbiome-derived antibiotic metabolite, Hydroxyisocaproate, using a systems biology approach to improve BV treatment.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

MicrobiologyeLifePeer-reviewedFeb 3, 2015

Mucosal effects of tenofovir 1% gel

Florian Hladik, Adam Burgener, Lamar Ballweber…·Ian McGowan

This study evaluates the mucosal effects of tenofovir 1% gel, finding broad biological impacts on rectal and vaginal tissues, including anti-inflammatory suppression and mitochondrial dysfunction.

DOI 10.7554/elife.04525

humanproteomics

𝕏 PostBluesky